IVF: INVO Bioscience Price to Sales

Symbol and logo of brand INVO Bioscience (IVF)

The price-to-sales ratio on GURU.Markets reflects the valuation dynamics of INVO Fertility Inc (IVF), where the metric stands at 0.40. Growth is driven by the popularity of the INVOcell system and the expansion of IVF centers. A fabless model with US assembly provides operational flexibility, while streamlined aviation logistics ensure the uninterrupted delivery of compact incubators, supporting the stability of the company's market quotes.

IVF (INVO Fertility) P/S Multiple history from 04/29/2025 to 11/13/2026

Analytical breakdowns for INVO Bioscience, Inc. (IVF)

- market price and analyst price targets:
Stock Quotes invobioscience.com|IVF - Analyst Consensus Forecast
- market capitalization information:
Market Value INVO Bioscience, Inc.|IVF - Enterprise Value
- shareholders' equity book value data:
Equity per Share INVO Fertility|IVF - Book Capitalization|Market Capitalization to Book Value invobioscience.com|IVF - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio INVO Fertility Inc|IVF - Long-Term Debt to Capital|Short-Term Debt to Capital INVO Fertility Corp|IVF - Company Debts|Debt to Book Capitalization Ratio INVO Bioscience, Inc.|IVF - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings INVO Fertility|Immediate Liquidity invobioscience.com
- net income and valuation multiples indicators:
IVF - Company Net Income|Projected Net Profit INVO Fertility Inc|IVF - Price to Earnings Ratio|Forward P/E Multiple INVO Bioscience|IVF - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio INVO Bioscience, Inc.|IVF - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months INVO Fertility|IVF - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months invobioscience.com|IVF - Earnings growth in current year|Expected net earnings per share growth next year INVO Fertility Inc
- issuer revenue and sales details:
IVF - Company Revenue|Company Revenue Forecast invobioscience.com|IVF - Market Cap to Revenue|Price to Expected Revenue Ratio INVO Bioscience, Inc.
Fundamental company analysis:invobioscience.com IVF
Original product of INVO Bioscience, Inc.

The P/S ratio determines the market value of a business relative to its annual sales volume, allowing for an assessment of revenue capitalization efficiency under conditions of limited liquidity. By analyzing the ratio of company value to annual revenue, an investor can see how the implementation of automated embryo monitoring systems and intelligent incubators by INVO Fertility Inc. (IVF) impacts the market valuation of the scalability of their technological solutions.

Who INVO Fertility Inc competes with

Market Cap to Revenue bostonscientific.com BSX|P/S Multiple EW (Edwards Lifesciences Corporation)|ResMed Inc (RMD) - Price to Sales|OmniPod - P/S Multiple|ZBH (Zimmer Biomet Holdings) - Market Cap to Revenue Ratio|COO: P/S Multiple|ALGN - Price-to-Revenue Coefficient|GMED (Globus Medical) - P/S Multiple|Market Cap to Revenue TransMedics Group Inc (TMDX)|P/S Multiple ATEC|P/S Multiple Artivion Corp (AORT)|Price-to-Revenue Ratio Enovis Corporation ENOV|integralife.com - Price-to-Revenue Ratio|ESTA: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio BBNX (Beta Bionics, Inc.)|IRMD: P/S Multiple|Price to Sales Embecta Health (EMBC)|Price-to-Revenue Ratio Tandem Diabetes Care|AXGN - Price-to-Revenue Multiple|Market Cap to Revenue SIBN (SI-BONE)|P/S Multiple Orthofix Medical (OFIX)|P/S Multiple BVS (Bioventus Corp)|Price-to-Revenue Coefficient OrthoPediatrics Corp (KIDS)|TMCI - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Market Cap to Revenue RxSight Inc|CLPT (ClearPoint Neuro Inc.) - P/S Multiple|Price to Sales Stereotaxis Corporation STXS|Price-to-Revenue Ratio Neuronetics, Inc. (STIM)|sightsciences.com - Market Cap to Revenue Ratio|Orchestra BioMed, Inc. - Market Cap to Revenue|Market Cap to Sales Volume ANIK (Anika Therapeutics Inc.)|InspireMD Corp - P/S Multiple|Price-to-Revenue Coefficient Jin Medical International ZJYL|vivani.com (VANI) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio XTNT|Market Cap to Revenue NMTC|Price-to-Revenue Ratio MODD|Price-to-Revenue Ratio Myomo, Inc (MYO)|COCH - Price to Sales|Vivos Therapeutics - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio NVNO|SINTX Technologies - P/S Multiple|Price-to-Sales Ratio TNON|LFWD: P/S Multiple|Price to Sales Autonomix Medical (AMIX)|Price-to-Revenue Ratio Bone Biologics|AXNX: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue BIOL (BIOLASE)|Market Cap to Sales Volume DYNT|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)